CompletedPhase 2/3

Fractional CO2 Laser Assisted Photodynamic Therapy

Denmark47 participantsStarted 2010-10

Plain-language summary

Nodular Basal Cell Carcinomas: Compare the efficacy and safety of conventional versus fractional laser assisted PDT for difficult to treat nodular cell carcinomas in the face. Actinic keratosis: Compare the efficacy and safety of conventional versus fractional laser assisted PDT for moderate to severe actinic keratoses located in the face and on the hands.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 or older * Skin type I-III * Fertile women using secure birth control * Moderate to severe actinic keratoses in the face or on the hands, * Difficult to treat nodular basal cell carcinomas in the face Exclusion Criteria: * Pregnancy or breast feeding patients * Patients with porphyria * Patients with Gorlins syndrome * Patients with a tendency to produce hypertrophic scars or keloids * Patients with known allergy to Metvix * Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic, dementia, mentally ill etc.) * Patients with pigmented or morphea basal cell carcinomas * Know herpes simplex virus infection in treatment areas

What they're measuring

Treatment response

Timeframe: 3 months

Reoccurrence

Timeframe: 12 months

Treatment response

Timeframe: 12 months

Trial details

NCT IDNCT01260987

SponsorBispebjerg Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-08

View on ClinicalTrials.gov More Actinic Keratosis trials